Steven Hass
Overview
Explore the profile of Steven Hass including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ogdie A, Hwang M, Pedro S, Veeranki P, Yi E, Hass S, et al.
Rheumatology (Oxford)
. 2022 Dec;
62(6):e182-e184.
PMID: 36469081
No abstract available.
2.
Merola J, Armstrong A, Phares S, Hass S, Yi E, Patil D, et al.
Am J Manag Care
. 2022 Nov;
28(11):e417-e425.
PMID: 36374660
Objectives: Nonmedical switching (NMS) is a change in a patient's treatment regimen for reasons other than lack of efficacy, intolerance, adverse effects, or poor adherence. We describe the impact of...
3.
Ogdie A, Hwang M, Veeranki P, Portelli A, Sison S, Shafrin J, et al.
J Manag Care Spec Pharm
. 2022 Aug;
28(9):997-1007.
PMID: 36001101
The Health Assessment Questionnaire Disability Index (HAQ-DI) has been validated and widely used in psoriatic arthritis (PsA) clinical trials for the assessment of patient functional status. Significant improvements in the...
4.
Mease P, Bhutani M, Hass S, Yi E, Hur P, Kim N
Rheumatol Ther
. 2021 Dec;
9(2):331-378.
PMID: 34962619
Introduction: Misclassification of spondyloarthritis (SpA) as rheumatoid arthritis (RA) may lead to delayed SpA diagnosis and suboptimal therapeutic outcomes. Here, we evaluate the literature on clinical manifestations in patients with...
5.
Long K, Smith C, Petersen R, Emerson J, Ransom J, Mielke M, et al.
Alzheimers Dement
. 2021 Sep;
18(3):393-407.
PMID: 34482623
Introduction: Efforts to model the cost-effectiveness of managing/modifying cognitive impairment lack reliable, objective, baseline medical, and nursing-home (NH) costs. Methods: A stratified-random sample of Olmsted County, MN, residents ages 70-89...
6.
Carr B, Giudice L, Dmowski W, OBrien C, Jiang P, Burke J, et al.
J Endometr Pelvic Pain Disord
. 2018 Oct;
5(3):105-115.
PMID: 30320043
Objective: The aim of this study was to estimate the efficacy of elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, for the treatment of endometriosis-associated pelvic pain. Methods: This was a...
7.
Marshall T, Pugh A, Fairchild A, Hass S
Value Health
. 2017 Dec;
20(10):1383-1393.
PMID: 29241898
Background: Effective treatment for advanced Parkinson disease (PD) uncontrolled with oral medication includes device-aided therapies such as deep brain stimulation (DBS) and continuous levodopa-carbidopa infusion to the duodenum via a...
8.
Freedman M, Montalban X, Miller A, Dive-Pouletty C, Hass S, Thangavelu K, et al.
Mult Scler Relat Disord
. 2016 Dec;
10:204-212.
PMID: 27919491
Dimethyl fumarate (DMF), fingolimod, and teriflunomide are oral disease-modifying therapies (DMTs) indicated for the treatment of relapsing-remitting multiple sclerosis. Despite well-established limitations of cross-trial comparisons, DMTs are still frequently compared...
9.
Vermersch P, Hobart J, Dive-Pouletty C, Bozzi S, Hass S, Coyle P
Mult Scler
. 2016 Jul;
23(4):604-613.
PMID: 27364322
Background: The Treatment Satisfaction Questionnaire for Medication (TSQM) was designed to assess patient treatment satisfaction in chronic diseases. Its performance has not been examined in multiple sclerosis (MS). The 14...
10.
Reed Johnson F, Hauber B, Ozdemir S, Siegel C, Hass S, Sands B
J Manag Care Pharm
. 2010 Sep;
16(8):616-28.
PMID: 20866166
Background: Crohn's disease is a serious and debilitating gastrointestinal disorder with a high, unmet need for new treatments. Biologic agents have the potential to alter the natural course of Crohn's...